Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer
C Buttigliero, M Tucci, V Bertaglia, F Vignani… - Cancer treatment …, 2015 - Elsevier
… survival, including enzalutamide and abiraterone, two new-… with abiraterone and 25% of
those treated with enzalutamide … of resistance to abiraterone and enzalutamide, and to discuss …
those treated with enzalutamide … of resistance to abiraterone and enzalutamide, and to discuss …
Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration‐resistant prostate cancer: a retrospective study
BL Maughan, B Luber, R Nadal, ES Antonarakis - The Prostate, 2017 - Wiley Online Library
… system for treatment with abiraterone and enzalutamide. Only patients that received
sequential therapy with abiraterone-to-enzalutamide or enzalutamide-to-abiraterone (without any …
sequential therapy with abiraterone-to-enzalutamide or enzalutamide-to-abiraterone (without any …
[HTML][HTML] Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
… abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer
… androgen-signaling–targeted inhibitor (abiraterone or enzalutamide). The trial was approved …
… androgen-signaling–targeted inhibitor (abiraterone or enzalutamide). The trial was approved …
Efficacy of abiraterone and enzalutamide in pre‐and postdocetaxel castration‐resistant prostate cancer: a trial‐level meta‐analysis
M Fang, M Nakazawa, ES Antonarakis, C Li - Prostate Cancer, 2017 - Wiley Online Library
… in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) … of abiraterone
and enzalutamide with respect to OS and PFS. In the predocetaxel setting, enzalutamide …
and enzalutamide with respect to OS and PFS. In the predocetaxel setting, enzalutamide …
Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
X Wang, H Yang, X Hu, W Wang, X Yu… - Journal of Oncology …, 2021 - journals.sagepub.com
… Our results demonstrated that enzalutamide was more efficacious than abiraterone for
patients with metastatic castration-resistant prostate cancer, but was associated with a …
patients with metastatic castration-resistant prostate cancer, but was associated with a …
Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide …
… Combining abiraterone with enzalutamide would not inhibit reactivation of AR independent
… for cancers more likely to benefit from the combination of enzalutamide and abiraterone, we …
… for cancers more likely to benefit from the combination of enzalutamide and abiraterone, we …
Abiraterone or Enzalutamide in Advanced Castration‐Resistant Prostate Cancer: An Indirect Comparison
A Chopra, M Georgieva, G Lopes, CM Yeo… - … Prostate, 2017 - Wiley Online Library
… of abiraterone acetate and enzalutamide in advanced CRPC. Our results show that in a
pre-docetaxel setting, enzalutamide … that enzalutamide may outperform AA with abiraterone in …
pre-docetaxel setting, enzalutamide … that enzalutamide may outperform AA with abiraterone in …
… versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis: Abiraterone versus enzalutamide in …
X Wang, S Wang, X Hu, X Yu… - … of Pharmacy & …, 2020 - journals.library.ualberta.ca
… ABSTRACT- Purpose: To compare the effectiveness and safety between abiraterone and
enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer (…
enzalutamide in the treatment of patients with metastatic castration-resistant prostate cancer (…
[HTML][HTML] Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two …
… and the second trial, which included enzalutamide, allocated 533 to the control group …
enzalutamide and abiraterone acetate were administered concurrently compared with abiraterone …
enzalutamide and abiraterone acetate were administered concurrently compared with abiraterone …
Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC).
E Efstathiou, MA Titus, S Wen, A SanMiguel, A Hoang… - 2014 - ascopubs.org
5000 Background: Co-targeting the androgen receptor (AR) and paracrine androgen biosynthesis
in mCRPC may be more effective than either alone. This study aims to evaluate safety…
in mCRPC may be more effective than either alone. This study aims to evaluate safety…
相关搜索
- abiraterone acetate and enzalutamide prostate cancer
- safety of enzalutamide prostate cancer
- combination with enzalutamide prostate cancer
- effects of enzalutamide prostate cancer
- meta analysis prostate cancer
- prostate cancer patients
- clinical activity prostate cancer
- outcomes of abiraterone prostate cancer
- metastatic prostate cancer
- bone metastatic castration resistant prostate cancer
- androgen receptor prostate cancer
- hormone therapy prostate cancer
- indirect comparison prostate cancer
- prostate cancer mcrpc abiraterone prednisone
- systematic review prostate cancer
- real world data analysis prostate cancer